Digirad Corporation

Company Details:

Company Symbol: DRAD
Sector: Health Services
Company Rating:
URL: http://www.digirad.com

Related Research

  • 03/15/17 Morning Note B. Riley AM Note: ACLS, AMSWA, CLRO (resuming coverage), DRAD, DSW, FTD, IPAR, IVAC, NMRX, NPTN, OCLR, OSIS, PRGX, RELY, RUBI (downgrade)
  • 02/27/17 Morning Note B. Riley AM Note: CROX, DRAD, FL, IDSY, IMMR, JCP (downgrade), NTRI, NWL, PRGO, PRGX, SHOO (upgrade), SQNS, TREC; Internet (NAME, XOXO), Semiconductors (AVGO, MRVL, NLST, ON, SLAB, SMTC)
  • 02/27/17 Update DRAD ($5.25, Buy; $6.70 PT): DRAD Reports Mixed 4Q16 Results, Management Holds Off on Initial Guidance but Indicates Normalized FCF Should Increase y-o-y; Maintaining Buy & $6.70 PT
  • 02/21/17 Morning Note B. Riley AM Note: AMSWA, DCO, DORM, DRAD, FL, IDCC, JAKK, MAT, PBH, STMP, TYPE, VFC, WMAR
  • 02/21/17 Update DRAD ($4.95, Buy; $6.70 PT): 4Q16 Preview: Estimates Seem Reasonable, But the Business can be Lumpy
  • 12/09/16 Morning Note B. Riley AM Note: AVGO, CHKE, CIEN, CTSO, DRAD, FNJN, FNSR, IDSY, LGF, LLNW, MEI, SMTC, VNCE; Footwear (BOOT, COLM, DECK, RCKY, VFC, WEYS)
  • 10/31/16 Morning Note B. Riley AM Note: CARB, CLX, DMRC, DRAD, EL, FLWS, GPX, IPHI, KTCC, LGF, NWL, RGC (upgrade), ROG, SANM, SHOO, SIMO, SPCB, SUP, TACT, TREC, VIAV; Internet, Semiconductors, Semi. Cap. Equipment, Software
  • 10/31/16 Update DRAD ($4.50, Buy; $6.70 PT): Reports 3Q16 Miss But Management Maintains 2016 Guidance, Implying A Strong Q4 Is Afoot; Maintaining Buy Rating While Reducing PT To $6.70 From $7.00
  • 10/26/16 Morning Note B. Riley AM Note: ACLS, AKAM, AMAT, AMC, AVGO, CKEC, CL, COLM, CTG, DECK, DRAD, FNJN, FORM, IIVI (upgrade), INTC, LRCX, NWL, P, PG, PRGX, RCKY, RNWK, SLAB, SWKS, TUES, TXN, UA, VVI, WMAR
  • 10/26/16 Update DRAD ($5.00, Buy; $7.00 PT): 3Q16 Preview: Anticipate In Line Results; Maintaining Buy Rating & $7.00 Price Target
  • 09/06/16 Update DRAD ($5.26, Buy; $7.00 PT): Transferring Coverage Of DRAD—DMS Health Integration Remains On Track While Synergies & Potential Tuck-in Acquisitions Provide Upside; Maintaining Buy & $7 PT
  • 09/06/16 Morning Note B. Riley AM Note: ACW, DRAD, FNSR, IDCC, ROVI
  • 07/29/16 Update DRAD ($5.69, Buy; $7.00 PT): Reported Q2 ’16 Mixed Results; Revenue and adj. EBITDA Below Our Estimates; FY Guidance Reaffirmed; Integration On Track
  • 07/29/16 Morning Note B. Riley AM Note: AVP, BC, BCOV, BRKS, CARB, CL, CLX, COHU, CSGP, DECK, DRAD, GOOGL, GPX, ISIL, KEM, KLAC, MCS, MRVL, NLS, NTCT, OUTR, PG, PRMW, RCKY, ROVI, RTEC, SQNS, STMP, TST, TYL, VVI, VSAT, WMAR; Internet and Optical Components Industry
  • 07/26/16 Update DRAD ($5.95, Buy; $7.00 PT): Q2 ’16 Earnings Preview: Expect In Line Results and Guidance; Enduring Organic and Acquisition Growth
  • 07/26/16 Morning Note B. Riley AM Note: AMC, CSGP, DMRC, DRAD, GPX, IPAR (upgrade), KEM, KMB, KTCC, NVDA, OUTR, RUBI, SANM, SIX, SONS, TRUE, TXN, YHOO; Software (NTCT, STMP, TYL, TYPE)
  • 05/02/16 Morning Note B. Riley AM Note: AMC, ARC, AXTI, DRAD, FN, IL, JCP, KTOS, NEWP, NTRI, NWL, OCLR, PRMW, REIS, ROVI, RWNK, SWKS, TACT, TUES, TYPE, VFC, VIAV, VSAT; Exhibitors, Optical (CIEN, FNSR, IPHI), Semis/SemiCap (ACLS, CAMT, MCHP ), Software (CALD, CSOD, GUID, NTCT)
  • 05/02/16 Update DRAD ($5.83, Buy; $7.00 PT): Reports Q1 ’16 Top and Bottom Line Results Above Our Estimates: Integration On Track; Slightly Raising Estimates and Maintaining Price Target
  • 04/26/16 Update DRAD ($5.60, Buy; $7.00 PT): Q1 ’16 Earnings Preview: Expect In Line Results and Guidance
  • 02/29/16 Morning Note B. Riley AM Note: ACW, CVU, DCO, DRAD, FL, JCP, LGF, PBH, PRGX, SMTC, UFAB, WMAR; Internet (DMD, PCOM, XOXO)
  • 02/29/16 Update DRAD ($5.28, Buy; $7.00 PT): Reports Q4 ’15 Bottom Line Results Above Our Estimates: Integration On Track; Slightly Raising Revenues and adj. EBITDA Estimates and Maintaining Price Target
  • 02/24/16 Desk Report B. Riley AM Note: ACLS, ARC, ATNY, CTG, DKS, DRAD, DTSI, DWA, FL, IMMR, JAKK, JCP, MRVL, NEWP, ROG, RUBI, SNDK, TROX, TST, WWW
  • 02/24/16 Update DRAD ($4.76, Buy; $7.00 PT): Q4 ’15 Earnings Preview: Expect In Line Results and Guidance
  • 11/02/15 Update DRAD ($5.92, Buy; $7.00 PT): Reports Q3 Results Above Our Estimates; Both Segments Growing; Acquisition On Track; Maintaining Buy Rating and Price Target
  • 11/02/15 Morning Note B. Riley AM Note: AVP, CL, CNK, COHR, CVU, DCO, DRAD, DWA, FTD, HZO, IDSY, LGF, LOV, NEWP, NLS, NTRI, NWL, OCLR, PCMI, RDEN, SRI, SUP, SWKS, SYRX, TREC, TYPE, UNTD, VPG, WMAR; November Focust List, Internet, Semiconductors & Semi. Cap. Equipment
  • 10/29/15 Update DRAD ($5.82, Buy; $7.00 PT): Q3 ‘15 Earnings Preview: Expect In Line Results and Guidance
  • 10/29/15 Morning Note B. Riley AM Note: AFOP, BLKB, CLX, CSGP, DHX, DMRC, DORM, DRAD, EL, FORM, IMAX, ISIL, NTRI, PCTI, ROG, ROVI, SIMO, SLAB, SONS, TYPE, YELP
  • 10/15/15 Morning Note B. Riley AM Note: ASML, BHE, DRAD, FLEX, LLTC, LOV, OUTR, PBH, PCCC, SNDK, VOXX, WWW
  • 10/15/15 Update DRAD ($4.81, Buy; $7.00 PT): Digirad Acquires DMS Health, Large Acquisition, and Immediately Accretive; Maintaining Buy Rating and Raising Price Target
  • 09/24/15 Morning Note B. Riley AM Note: ABTL, AMRK, DRAD, JCP; Semi. Cap. Equipment (ASML, COHU, CSCD, KLAC, KLIC, LRCX, RTEC)
  • 09/24/15 Update DRAD ($3.87, Buy; $5.25 PT): Non-Deal Roadshow Highlights; Maintaining Buy Rating and Price Target
  • 08/10/15 Update DRAD ($4.10, Buy; $5.25 PT): Reports Q1 Results Slightly Below Our Estimates; Both Segments Growing; Maintaining Buy Rating and Price Target
  • 08/05/15 Morning Note Morning Notes: ACLS, BOOT, CLRO, CSOD, DRAD, DWA, ELNK, EMKR, EVOL, EXAR, HGG, IIVI, KLIC, LITE, NAME, NTCT, ODP, OSTK, PBH, PCOM, PCTI, PRMW, RDEN, RLD, STMP, TREC, TROX, UEIC, UNTD, VIAV, ZUMZ; The Weiser Consumer (AVP, CL, CLX, NTRI, NWL, PG, PRGO)
  • 08/05/15 Update DRAD ($4.29, Buy; $5.25 PT): Q2 ‘15 Earnings Preview: Expect Results In-Line with our Estimates
  • 07/23/15 Morning Note Morning Notes: AFOP, CIEN, DLB, DMRC, DRAD, EGHT, HZO, IPAR, JAKK, PII, RCKY, RNWK, SIX, SNDK, TIVO, TRUE, TUP, TXN, TYL, TYPE, VFC, YELP
  • 07/22/15 Initiation of Coverage DRAD ($4.20, Buy; $5.25 PT): Initiating Coverage with a Buy Rating and $5.25 Price Target